+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia

The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia

Journal of Invasive Cardiology 18(5): 212-218

Intracoronary mononuclear cell therapy may produce angiogenesis in chronic myocardial ischemia. Potential complications include periprocedural infarction secondary to: reduced coronary blood flow; hyperviscosity from the cell preparation; or microvascular dysfunction. To date, no studies to evaluate these potential complications have been reported. The objective of this report was to study the safety and feasibility of intracoronary injections of autologous bone marrow mononuclear cells in a porcine chronic myocardial ischemia model. Domestic pigs (n = 5) underwent ameroid cuff placement of the left circumflex artery. Bone marrow-derived mononuclear cells [15 x 10(6) cells] labeled with CM dioctadecyl tetramethylindocarbocyanine were given by intracoronary injection. Animals were sacrificed, and hearts and vital organs were inspected grossly and by histopathology, and bone marrow underwent immunofluorescence microscopy. Troponin I levels, gross inspection and histopathology did not reveal evidence of myocardial infarction. Labeled cells were observed in perivascular structures in myocardium at the injection site in all animals and in the spleen from one animal. Bone marrow aspirates indicated labeled cells. Intracoronary injection of autologous mononuclear cells in a porcine chronic myocardial ischemia model appears safe. Intracoronary injection resulted in cell localization in the perivascular areas of myocardium supplied by the injected vessel. Cell localization was observed only in the spleen in just one animal. Labeled cells were identified in bone marrow aspirates from three animals following injection, suggesting a role for bone marrow engraftment and repopulation as a possible mechanism for progenitor cell localization in myocardium.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 050728212

Download citation: RISBibTeXText

PMID: 16670448

DOI: 10.1016/j.carrev.2006.03.023

Related references

Effects of Intracoronary Administration of Autologous Adipose Tissue-Derived Stem Cells on Acute Myocardial Infarction in a Porcine Model. Yonsei Medical Journal 56(6): 1522-1529, 2015

Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scandinavian Cardiovascular Journal 39(3): 150-158, 2005

Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128(2): 122-131, 2013

Autologous transplantation of EPCs encoding FGF1 gene promotes neovascularization in a porcine model of chronic myocardial ischemia. International Journal of Cardiology 135(2): 223-232, 2009

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Deutsche Medizinische Wochenschrift 126(34-35): 932-938, 2001

Induced pluripotent stem cell transplantation in the treatment of porcine chronic myocardial ischemia. Annals of Thoracic Surgery 98(6): 2130-2137, 2014

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. American Heart Journal 153(2): 212.E1-7, 2007

Systematic review on safety of intracoronary autologous bone marrow stem cells transfer in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 36(8): 679-684, 2008

Safety and efficacy of intracoronary transplantation of G-CSF mobilized autologous peripheral blood stem cells in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 34(2): 99-102, 2006

Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. American Heart Journal 154(4): 710.E1-8, 2007

Intracoronary administration of autologous bone marrow stem cell transplant in myocardial infarction. Jpma. Journal of the Pakistan Medical Association 61(1): 3-5, 2011

Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury. Journal of Translational Medicine 15(1): 56, 2017

Feasibility and safety of autologous intracoronary stem cell transplantation in patients of non ischemic dilated cardiomyopathy. Indian Heart Journal 59(6): 511-514, 2009

Effect of intracoronary transplantation of autologous bone marrow mononuclear cells on myocardial ischemia reperfusion injury in mini-swine model. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 30(1): 86-90, 2008

Myocardial rescue with autologous mitochondrial transplantation in a porcine model of ischemia/reperfusion. Journal of Thoracic and Cardiovascular Surgery 153(4): 934-943, 2017